Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The role of tumor-infiltrating immune cells in the early metastatic invasion of colorectal cancer is unknown. METHODS: We studied pathological signs of early metastatic invasion (venous emboli and lymphatic and perineural invasion) in 959 specimens of resected colorectal cancer. The local immune response within the tumor was studied by flow cytometry (39 tumors), low-density-array real-time polymerase-chain-reaction assay (75 tumors), and tissue microarrays (415 tumors). RESULTS: Univariate analysis showed significant differences in disease-free and overall survival according to the presence or absence of histologic signs of early metastatic invasion (P<0.001). Multivariate Cox analysis showed that an early conventional pathological tumor-node-metastasis stage (P<0.001) and the absence of early metastatic invasion (P=0.04) were independently associated with increased survival. As compared with tumors with signs of early metastatic invasion, tumors without such signs had increased infiltrates of immune cells and increased levels of messenger RNA (mRNA) for products of type 1 helper effector T cells (CD8, T-BET [T-box transcription factor 21], interferon regulatory factor 1, interferon-gamma, granulysin, and granzyme B) but not increased levels of inflammatory mediators or immunosuppressive molecules. The two types of tumors had significant differences in the levels of expression of 65 combinations of T-cell markers, and hierarchical clustering showed that markers of T-cell migration, activation, and differentiation were increased in tumors without signs of early metastatic invasion. The latter type of tumors also had increased numbers of CD8+ T cells, ranging from early memory (CD45RO+CCR7-CD28+CD27+) to effector memory (CD45RO+CCR7-CD28-CD27-) T cells. The presence of high levels of infiltrating memory CD45RO+ cells, evaluated immunohistochemically, correlated with the absence of signs of early metastatic invasion, a less advanced pathological stage, and increased survival. CONCLUSIONS: Signs of an immune response within colorectal cancers are associated with the absence of pathological evidence of early metastatic invasion and with prolonged survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Examination of the lymphocytes that correlated with such beneficial outcomes has repeatedly implicated effector and memory CD8 + T cell and NK cell populations (136-141).”
From Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance (2021) · cites this paper as [136]
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
TNM Classification of Malignant Tumors
Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,330
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
TNM Classification of Malignant Tumours
(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,946
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
Research works printed but not linked: 2
- 10.1002/(sici)1097-0142(20000401)88:7<1739::aid-cncr30>3.0.co;2-t · DOI · Paper page
- 10.1002/(sici)1097-0215(19990621)84:3<326::aid-ijc22>3.0.co;2-k · DOI · Paper page
Cited by
Items 501–600 of 1,001
Guan, Y., Kraus, S. G., Quaney, M. J., Daniëls, M. A., Mitchem, J. B., & Teixeiro, E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00586 · Cited by 78
Cariani, E., Pilli, M., Zerbini, A., Rota, C., Olivani, A., Pelosi, G., Schianchi, C., Soliani, P., Campanini, N., Silini, E. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032493 · Cited by 75
“Phenotyping of the intratumoral T-cells showed that high levels of memory T-cells correlated with better survival in colon cancer [16] and was associated with the expression of genes involved in Th1 adaptive immunity [17].”
BackgroundPrizment, A. E., Vierkant, R. A., Smyrk, T. C., Tillmans, L. S., Nelson, H. H., Lynch, C. F., Pengo, T., Thibodeau, S. N., Church, T. R., Cerhan, J. R., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0641 · Cited by 83
“demonstrated that the type, density, and location of total lymphocytes (CD3þ), cytotoxic T lymphocytes (CTL, or CD8þ), and memory T lymphocytes correlated with disease-free and overall survival in colorectal cancer patients, and indicated the superiority of immune infiltrates over TNM staging in predicting patients' s…”
Danger signals: Chemotherapy enhancers?
Rivera Vargas, T., & Apetoh, L. (2017) · Immunological Reviews · doi:10.1111/imr.12581 · Cited by 74
Jia, Q., Zhou, J., Chen, G., Shi, Y., Yu, H., Guan, P. F., Lin, R., Jiang, N. J., Yu, P.-W., Li, Q.-J., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.1001230 · Cited by 73
“This directly led to the hypothesis that TAA-specific TMs play a central role in post-surgery surveillance against tumor recurrence.(4,10) Despite further study on larger cohort is needed to determine the precise magnitude of this favorable effect, our tissue-specific repertoire analyses indicated that the prognosis o…”
BackgroundMolecular profiling and risk stratification of adenocarcinoma of the colon
Mutch, M. G. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20915 · Cited by 89
“[80] demonstrated that the pathologic features of lymph node metastasis, lymphovascular, and perineural invasion were risk factors for distant metastasis and a poorer survival.”
BackgroundIto, K., & Ralph, S. J. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9471-7 · Cited by 75
“correlates with increased metastases and poorer overall survivals [43].”
BackgroundTremelimumab: A Review of Development to Date in Solid Tumors
Tarhini, A. A. (2013) · Immunotherapy · doi:10.2217/imt.13.9 · Cited by 76
Immune cells: plastic players along colorectal cancer progression
Caro, G. D., Marchesi, F., Laghi, L., & Grizzi, F. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12117 · Cited by 79
“In CRC, many clinical studies depicted densities of infiltrating immune cells as positive prognostic factors [13–15, 48–53].”
BackgroundLi, G., Yang, Q., Zhu, Y., Wang, H.-R., Chen, X., Zhang, X., & Lu, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067401 · Cited by 74
“[1–5]”
Upregulation of MICA on high-grade invasive operable breast carcinoma.
Madjd, Z., Spendlove, I., Moss, R. S., Bevin, S., Pinder, S. E., Watson, N. F., Ellis, I. O., & Durrant, L. G. (2007) · PubMed Central · Cited by 74
Kistner, L., Doll, D., Holtorf, A., Nitsche, U., & Janssen, K. (2017) · Oncotarget · doi:10.18632/oncotarget.21286 · Cited by 80
“The density of T-lymphocytes has been proposed as prognostic indicator that outperforms the current clinical staging system [13, 14, 44-46].”
BackgroundMethodDendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4.
Kaliński, P. (2009) · PubMed · Cited by 88
Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapies
Liu, J., Blake, S. J., Smyth, M. J., & Teng, M. W. (2014) · Clinical & Translational Immunology · doi:10.1038/cti.2014.18 · Cited by 73
Shaler, C. R., Tun‐Abraham, M. E., Skaro, A. I., Khazaie, K., Corbett, A. J., Mele, T. S., Hernandez‐Alejandro, R., & Haeryfar, S. M. M. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2050-7 · Cited by 79
“These include intratumoral NK cells [6, 7], invariant natural killer T (NKT) cells [8], macrophages [9] and memory, T helper 1 (TH1)-polarized and cytotoxic CD8+ T cells [10, 11].”
BackgroundThe renaissance of anti‐neoplastic immunity from tumor cell demise
Ma, Y., Pitt, J. M., Li, Q., & Yang, H. (2017) · Immunological Reviews · doi:10.1111/imr.12586 · Cited by 73
Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?
Ghiringhelli, F., & Fumet, J.-D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01816 · Cited by 84
“Jerome Galon’s team’s publications have shown that time to recurrence and overall survival strongly correlate with the strength of the in-situ adaptive immune reaction in the colon tumor core and invasive margin (2, 3).”
BackgroundTriozzi, P. L., Stirling, E. R., Song, Q., Westwood, B., Kooshki, M., Forbes, M. E., Holbrook, B. C., Cook, K. L., Alexander‐Miller, M. A., Miller, L. D., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3114 · Cited by 78
Kroemer, G., Galluzzi, L., Zitvogel, L., & Fridman, W. H. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1058597 · Cited by 73
“The fact that CRC does not respond to checkpoint blockers appears somehow paradoxical, since the first sophisticated analyses of the immunological tumor microenvironment have been performed on CRC specimens, yielding the conclusion that the “immune contexture” has a critical impact on the fate of patients.(4,5) The te…”
BackgroundSelf-citationSong, G., Wang, X., Jia, J., Yuan, Y., Fengling, W., Zhou, X., Yang, H., Ren, J., Gu, J., & Lyerly, H. K. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1424-8 · Cited by 78
“Previous studies showed an expansion of CD8CD28 lymphocyte subsets in patients with malignancies [20, 41–43] and that increased CD8CD28lymphocyte subsets in cancer patients may be associated with advanced stages of disease and poor survival [15, 44, 45].”
ResultToiyama, Y. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1247 · Cited by 73
Li, Y.-W., Qiu, S., Fan, J., Gao, Q., Zhou, J., Xiao, Y., Xu, Y., Wang, X., Sun, J., & Huang, X. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0469-0 · Cited by 75
Eyob, H., Ekiz, H. A., DeRose, Y. S., Waltz, S. E., Williams, M. A., & Welm, A. L. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0480 · Cited by 73
“15 It has long been known that infiltration of CD8 CTLs into tumors is a useful prognostic indicator for various types of tumors (37-39).”
Webster, W. S., Thompson, R. H., Harris, K. J., Frigola, X., Kuntz, S., Inman, B. A., & Dong, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2860 · Cited by 73
“In certain tumors, such as colorectal carcinoma, tumor infiltration by effector memory CD8 T cells is associated with a better prognosis (2).”
BackgroundAwad, M. M., Jones, R. E., Liu, H., Lizotte, P. H., Ivanova, E. V., Kulkarni, M., Herter-Sprie, G. S., Liao, X., Santos, A. A., Bittinger, M. A., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0171 · Cited by 73
“Although the presence of tumor-infiltrating lymphocytes (TIL) may be a favorable prognostic factor in some cancers (34, 35), it is not clear whether TILs are predictive of a response to immune checkpoint blockade.”
BackgroundResults and challenges of immune checkpoint inhibitors in colorectal cancer
Emambux, S., Tachon, G., Junca, A., & Tougeron, D. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1445222 · Cited by 79
Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer
Karlsson, M., Marits, P., Dahl, K., Dagöö, T., Enerbäck, S., Thörn, M., & Winqvist, O. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0920-8 · Cited by 75
“All five patients with stage II disease were identified as high risk according to the vascular emboli, lymphatic invasion, and perineural invasion (VELIPI) criteria.(24) They had aggressive tumor characteristics such as ulcerations, vascular or perineural invasion.”
BackgroundNew Insights into the Role of the Immune Microenvironment in Breast Carcinoma
de la Cruz‐Merino, L., Barco-Sánchez, A., Henao, F., Fernández, E. N., Benítez, A. V., Molina, J. B., Martínez-Peinado, A., López, A. G., Borrego, M. R., de Villena, M. C. M., et al. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/785317 · Cited by 85
“Tumor infiltration by TIL is well recognized as a good prognosis factor in multiple solid human neoplasms [7–10].”
BackgroundMcCoy, M. J., Hemmings, C., Miller, T. J., Austin, S. J., Bulsara, M. K., Zeps, N., Nowak, A. K., Lake, R., & Platell, C. F. E. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.427 · Cited by 82
“In colorectal cancer, the density of tumour-infiltrating T cells is a strong prognostic indicator, even after adjustment for clinical and molecular risk factors (Pages et al, 2005; Galon et al, 2006; Nosho et al, 2010).”
BackgroundMennonna, D., Maccalli, C., Romano, M. C., Garavaglia, C., Capocefalo, F., Bordoni, R., Severgnini, M., Bellis, G. D., Sidney, J., Sette, A., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309453 · Cited by 76
Harnessing dendritic cells in cancer
Apétoh, L., Locher, C., Ghiringhelli, F., Kroemer, G., & Zitvogel, L. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.003 · Cited by 89
Immune cell infiltration of primary and metastatic lesions: Mechanisms and clinical impact
Talmadge, J. E. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.002 · Cited by 83
Caratelli, S., Sconocchia, T., Arriga, R., Coppola, A., Lanzilli, G., Lauro, D., Venditti, A., Principe, M. I. D., Buccisano, F., Maurillo, L., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00457 · Cited by 71
“A novel approach useful to overcome this NK cell limitation and to enhance mAbs’ cell-mediated cytotoxicity utilizes FcγCR-engineered T cells since CTLs easily infiltrate the tumor microenvironment and their presence is closely associated with a favorable course of the disease in many types of cancers (34).”
BackgroundThe role of B lymphocytes in the immuno-biology of non-small-cell lung cancer
Patel, A. J., Richter, A. G., Drayson, M. T., & Middleton, G. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02461-2 · Cited by 80
Hofman, P. M., Butori, C., Havet, K., Hofman, V., Selva, É., Guevara, N., Santini, J., & Obberghen‐Schilling, E. V. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604245 · Cited by 71
“Eighty-seven per cent of the carcinomas were keratinising, with a range of grades: grade I (n¼ 27), grade II (n¼ 94), and grade III (n¼ 55).”
BackgroundMethodPolarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors
Kaliński, P., & Okada, H. (2010) · Seminars in Immunology · doi:10.1016/j.smim.2010.03.002 · Cited by 84
Adoptive T-cell therapy improves treatment of canine non–Hodgkin lymphoma post chemotherapy
O'Connor, C. M., Sheppard, S., Hartline, C. A., Huls, H., Johnson, M., Palla, S. L., Maiti, S., Ma, W., Davis, R. E., Craig, S., et al. (2012) · Scientific Reports · doi:10.1038/srep00249 · Cited by 71
Wang, Y., Sun, J., Ma, C., Gao, W., Song, B., Xue, H., Chen, W., Chen, X., Zhang, Y., Shao, Q., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152599 · Cited by 72
Cavnar, M. J., Turcotte, S., Katz, S. C., Kuk, D., Gönen, M., Shia, J., Allen, P. J., Balachandran, V. P., D’Angelica, M. I., Kingham, T. P., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5812-8 · Cited by 71
Lee, H. J., Lee, J.-J., Song, I. H., Park, I. A., Kang, J. K., Yu, J. H., Ahn, J., & Gong, G. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3438-8 · Cited by 80
“Several studies have shown that the presence of tumorinfiltrating lymphocytes (TILs) in cancer tissue is associated with an improved outcome [9, 10] and that the immune system participates in elimination of tumor cells and control of tumor growth [11, 12].”
BackgroundTada, K., Kitano, S., Shoji, H., Nishimura, T., Shimada, Y., Nagashima, K., Aoki, K., Hiraoka, N., Honma, Y., Iwasa, S., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0298 · Cited by 76
“In a more detailed analysis of the infiltrating T cells, the quantity of CD45ROþ cells (memory T cells) or effector memory (TEM) cells in a colorectal tumor was shown to have strong prognostic significance after surgery (12, 13).”
BackgroundLatest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update
Boukouris, A. E., Theochari, M., Stefanou, D. T., Papalambros, A., Felekouras, E. S., Gogas, H. J., & Ziogas, D. C. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103663 · Cited by 85
Søndergaard, H., Frederiksen, K. S., Thygesen, P., et al. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0285-4 · Cited by 70
“The benefit of TILs and specifically CD8 TILs and the CD8/CD4 TIL ratio have also been shown in several different human cancers where they were predictive of improved survival [9,12,21,22,28,30].”
BackgroundThimme, R., Neagu, M., Boettler, T., Neumann‐Haefelin, C., Kersting, N., Geißler, M., Makowiec, F., Obermaier, R., Hopt, U. T., Blum, H. E., et al. (2008) · Hepatology · doi:10.1002/hep.22535 · Cited by 80
Sun, C., Xu, J., Song, J., Liu, C., Wang, J., Weng, C., Sun, H., Wei, H., Xiao, W., Sun, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5801 · Cited by 75
“Analogously, this prognostic effect of CD8CT constantly been confirmed in a variety of tumours such as epithelial ovarian cancer [16-17], breast cancer [18], prostate cancer [19], renal cell cancer [20], non-small cell lung cancer [21], colorectal cancer [22] and esophageal cancer [23], suggesting the great potential…”
BackgroundBerthel, A., Zoernig, I., Valous, N. A., Kahlert, C., Klupp, F., Ulrich, A. B., Weitz, J., Jaeger, D., & Halama, N. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1286436 · Cited by 71
Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression
Yu, M., Bin, L., Liu, Y., Me, Y., Wang, L., & Zhang, P. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6065 · Cited by 75
“For example, the local intratumoral inflammatory response, as evidenced by a high density of tumor‑infiltrating lymphocytes, is considered to be a prognostic indicator for several types of malignancy, including CRC (9,10).”
InfluentialLu, C., Yang, D., Klement, J. D., Oh, I. K., Savage, N. M., Waller, J. L., Colby, A. H., Grinstaff, M. W., Oberlies, N. H., Pearce, C. J., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0126 · Cited by 68
“Cancer Immunol Res; 7(3) March 2019 Cancer Immunology Research 422”
BackgroundInfluentialTherapeutic Targeting of the Colorectal Tumor Stroma
Fridman, W. H., Miller, I. S., Sautès‐Fridman, C., & Byrne, A. T. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.09.045 · Cited by 79
Self-citationLiu, R. B., Engels, B., Schreiber, K., Ciszewski, C., Schietinger, A., Schreiber, H., & Jabri, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301022110 · Cited by 69
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
THIERS, B. H. (2006) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70054-6 · Cited by 69
CCL5-deficiency enhances intratumoral infiltration of CD8+ T cells in colorectal cancer
Zhang, S., Zhong, M., Wang, C., Xu, Y., Gao, W.-Q., & Zhang, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0796-2 · Cited by 68
Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues
Muthuswamy, R., Okada, N. J., Jenkins, F. J., McGuire, K. P., McAuliffe, P. F., Zeh, H. J., Bartlett, D. L., Wallace, C. T., Watkins, S. C., Henning, J. D., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.008 · Cited by 74
“…the immune status within the TME (Apetoh et al., 2015; Curiel et al., 2004; Fox et al., 2012; Gabrilovich, 2004; Gabrilovich et al., 2012; Galon et al., 2006; Kryczek et al., 2009; Ostrand-Rosenberg et al., 2012; Pages et al., 2005; Rabinovich et al., 2007; Sato et al., 2005; Zhang et al., 2003).”
Granulysin: killer lymphocyte safeguard against microbes
Dotiwala, F., & Lieberman, J. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.04.013 · Cited by 70
Kreidieh, M., Mukherji, D., Temraz, S. N., & Shamseddine, A. I. (2020) · BioMed Research International · doi:10.1155/2020/9037217 · Cited by 80
Xu, F., Zhan, X., Zheng, X., Xu, H., Li, Y., Huang, X., Lin, L., & Chen, Y. (2020) · Genomics · doi:10.1016/j.ygeno.2020.08.014 · Cited by 83
Boshuizen, J., Pencheva, N., Krijgsman, O., Altimari, D. M. D., Castro, P. G., de Bruijn, B., Ligtenberg, M. A., den Heuvel, E. G.-V., Vredevoogd, D. W., Song, J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-0434 · Cited by 74
“They correlate with reduced metastatic invasion and increased overall survival, and have been shown to expand in melanoma patients in response to PD-1 blockade (40, 41).”
BackgroundNerves in gastrointestinal cancer: from mechanism to modulations
Vaes, N., Idris, M., Boesmans, W., Alves, M. M., & Melotte, V. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00669-9 · Cited by 75
Lee, I., Huang, Y., Chau, G., Huo, T., Su, C., Wu, J., & Lin, H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28311 · Cited by 71
“CD45RO(1) T cells, which represent subsets of T cells with effecter and memory functions, have been shown to correlate with prognosis in patients with colon cancer.(39) As shown in Supporting Information Table 2, a higher frequency of CD45RO(1)CD4(1) T cells correlated with more advanced tumor stage and larger tumor s…”
A Role for T-Lymphocytes in Human Breast Cancer and in Canine Mammary Tumors
Carvalho, M. I., Pires, I. C. R., Prada, J., & QUEIROGA, F. L. (2014) · BioMed Research International · doi:10.1155/2014/130894 · Cited by 81
“In humans, the study of the inflammatory infiltrate, mainly T-lymphocytes, has been subject of great interest associated not only with breast cancer [19, 23, 39], but also with other types of neoplasias, including seminoma [40, 41], melanoma [42, 43], colorectal [44, 45], cervical [46], ovarian [47, 48], urothelial [4…”
Bae, J., PRABHALA, R. H., Voskertchian, A., Brown, A., Maguire, C., Richardson, P. G. G., Dranoff, G., Anderson, K. C., & Munshi, N. C. (2014) · Leukemia · doi:10.1038/leu.2014.159 · Cited by 68
“37,38 39-42 In these studies, we generated MP-CTL having effective anti-MM activities in all HLA-A2 + SMM patients tested (n=8), thereby validating the immunogenicity of the XBP1 US/XBP1 SP/CD138/CS1 multipeptide and its potential as a vaccine for SMM patients.”
Nguyen, G. H., Schetter, A. J., Chou, D. B., Bowman, E. D., Zhao, R., Hawkes, J. E., Mathé, E. A., Kumamoto, K., Zhao, Y., Budhu, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1110 · Cited by 69
“We and others have reported that inflammation-associated gene signatures can be used as indicators of prognosis and tumor burden in liver (10), lung (11), colorectal cancer patients (12-14).”
Bell, R. B., Leidner, R. S., Crittenden, M. R., Curti, B. D., Feng, Z., Montler, R. D., Gough, M. J., Fox, B. A., Weinberg, A. D., & Urba, W. J. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.11.009 · Cited by 73
“001) more prognostic than AJCC TNM staging in patients with colon cancer [8,9].”
BackgroundDendritic and mast cell involvement in the inflammatory response to primary malignant bone tumours
Inagaki, Y., Hookway, E., Williams, K. A., Hassan, A. B., Oppermann, U., Tanaka, Y., Soilleux, E., & Athanasou, N. A. (2016) · Clinical Sarcoma Research · doi:10.1186/s13569-016-0053-3 · Cited by 68
“In contrast, lymphocytic infiltration, predominantly of T lymphocytes, correlates with improved survival in several cancers [10–12].”
BackgroundHuang, K. C., Chiang, S., Ke, T., Chen, T.-W., Lan, Y., You, Y., Shiau, A., Chen, W. T., & Chao, K. S. C. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2109-5 · Cited by 74
“Based on these pioneering studies and many subsequent investigations, the presence of CD8+ TILs has been established as an independent prognostic factor in CRC and has an even stronger prognostic significance than conventional TNM staging [13, 14].”
BackgroundInfluentialZhang, J., Caruso, F. P., Sa, J. K., Justesen, S. F. L., Nam, D., Sims, P. A., Ceccarelli, M., Lasorella, A., & Iavarone, A. (2019) · Communications Biology · doi:10.1038/s42003-019-0369-7 · Cited by 72
Extracellular Granzyme A Promotes Colorectal Cancer Development by Enhancing Gut Inflammation
Santiago, L., Castro, M., Pamplona, R. S., Garzón-Tituaña, M., Ramírez-Labrada, A., Tapia, E., Moreno, V. R., Layunta, E., Gil‐Gómez, G., Garrido, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107847 · Cited by 72
“GzmB provides cytotoxic activity against cancer cells and is a positive prognostic marker in human CRC (Galon et al., 2012; Pagès et al., 2005; Salama et al., 2011).”
BackgroundPrognostic value of innate and adaptive immunity in colorectal cancer
Grizzi, F., Bianchi, P. P., Malesci, A., & Laghi, L. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i2.174 · Cited by 83
Chew, A. C., Salama, P. R., Robbshaw, A., Klopcic, B. R. S., Zeps, N., Platell, C. F. E., & Lawrance, I. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022047 · Cited by 67
“The presence of a high density of CD8 T cells is also associated with the absence of tumour invasion, an earlier disease stage and improved patient survival[11,12].”
BackgroundA Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Zlobec, I., Suter, G., Perren, A. A., et al. (2014) · Journal of Visualized Experiments · doi:10.3791/51893 · Cited by 67
inducTION of mage‐A3 and HPV‐16 immunity by Trojan vaccines in patients with head and neck carcinoma
Voskens, C., Sewell, D. A., Hertzano, R. P., DeSanto, J. M., Rollins, S., Lee, M.-H., Taylor, R., Wolf, J. S., Suntharalingam, M., Gastman, B., et al. (2012) · Head & Neck · doi:10.1002/hed.22004 · Cited by 68
“However, data from patients with colon cancer, demonstrate that the presence of both CD27/CD28 double negative and double positive CD8 cells in the tumor microenvironment are independently associated with reduced metastases.(35) Further studies will be required to definitively characterize the function of these antige…”
BackgroundInoue, Y., Hazama, S., Suzuki, N., Tokumitsu, Y., Kanekiyo, S., Tomochika, S., Tsunedomi, R., Tokuhisa, Y., Iida, M., Sakamoto, K., et al. (2017) · Cancer Science · doi:10.1111/cas.13162 · Cited by 67
A comprehensive review of immunotherapies in prostate cancer
Maia, M. C., & Hansen, A. R. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.026 · Cited by 71
The signature of liver cancer in immune cells DNA methylation
Zhang, Y., Sophie Petropoulos, A., Liu, J., Cheishvili, D., Zhou, R., Dymov, S., Li, K., Li, N., & Szyf, M. (2018) · Clinical Epigenetics · doi:10.1186/s13148-017-0436-1 · Cited by 69
Xin Min, Z. H. O. U., Du, Y., Xu, J. L., Huang, Z., Qiu, T., Wang, X., Qian, J., Zhu, W., & Liu, P. (2014) · Tumor Biology · doi:10.1007/s13277-014-2504-x · Cited by 69
Wyk, H. C. V., Going, J. J., Horgan, P. G., & McMillan, D. C. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.005 · Cited by 76
“Perineural invasion in colorectal cancer has been reported as an independent prognostic factor [8, 9, 10] however, is not always assessed and reported.”
BackgroundPrognosis according to histochemical analysis of liver metastases removed at liver resection
Brunner, S. M., Kesselring, R., Rubner, C., Martin, M., Jeiter, T., Boerner, T., Ruemmele, P., Schlitt, H. J., & Fichtner‐Feigl, S. (2014) · British journal of surgery · doi:10.1002/bjs.9627 · Cited by 72
Molecular Pathways and Cellular Metabolism in Colorectal Cancer
Hagland, H. R., Berg, M., Jolma, I. W., Carlsen, A., & Søreide, K. (2013) · Digestive Surgery · doi:10.1159/000347166 · Cited by 71
Toh, H. C., Wang, W.-W., Chia, W. K., Kvistborg, P., Sun, L. J., Teo, K., Phoon, Y. P., Soe, Y., Tan, S. H., Hee, S. W., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1537 · Cited by 67
“org tentially allow the modulation of T cells by cancer immunotherapeutic approaches (12, 13).”
BackgroundChang, K., Huang, G.-C., Jones, D., & Lin, Y.-H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0504 · Cited by 73
Iseki, Y., Shibutani, M., Maeda, K., Nagahara, H., Fukuoka, T., Matsutani, S., Kashiwagi, S., Tanaka, H., Hirakawa, K., & Ohira, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192744 · Cited by 75
Turner, N. H., Wong, H., Templeton, A. J., Tripathy, S., Rogers, T. W., Croxford, M. A., Jones, I. T., Sinnathamby, M., Desai, J., Tie, J., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29805 · Cited by 72
“A robust intratumoral inflammatory response, as represented by a high density of tumor infiltrating lymphocytes (TILs), is recognized as a good prognostic marker across multiple malignancies,(9) including colon cancer.(10,11) Tumor infiltration by chronic inflammatory cells (CIC) comprising lymphocytes, plasma cells a…”
BackgroundJanson, P., Marits, P., Thörn, M., OHLSSON, R. I., & Winqvist, O. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2878 · Cited by 69
“The majority of tumor-infiltrating T lymphocytes belong to the memory T cell pool (23).”
BackgroundClinically important aspects of lymph node assessment in colon cancer
Wright, F. C., Law, C., Berry, S., et al. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21226 · Cited by 65
“[35] also confirmed the lack of association between number of lymph nodes assessed and rate of lymph node positivity and suggested that perhaps patients with more nodes may have a greater survival because they mount a stronger immunologic response to their cancers [36].”
BackgroundThe role of innate immunity in spontaneous regression of cancer
Thomas, J., & Badini, M. (2011) · Indian Journal of Cancer · doi:10.4103/0019-509x.82887 · Cited by 63
“[25] An interesting facet that is noticed in spontaneous regression is both the diversity of organisms associated and the speed at which the regression occurs.”
BackgroundNagasaki, T., Akiyoshi, T., Fujimoto, Y., Konishi, T., Nagayama, S., Fukunaga, Y., & Ueno, M. (2015) · Digestive Surgery · doi:10.1159/000441396 · Cited by 70
Masuda, K., Kornberg, A. E., Miller, J. D., Lin, S., Suek, N., Botella, T., Secener, K., Baccarella, A., Cheng, L., Ingham, M. A., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.154646 · Cited by 68
Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules
McMullen, T. P. W., Lai, R. L., Dabbagh, L., Wallace, T., & de Gara, C. J. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04147.x · Cited by 66
Liang, L., Zhu, J. Y., Jia, H., Huang, L., Li, D., Li, Q., & Li, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5835 · Cited by 64
“Moreover, Pages et al [32] also demonstrated that early metastatic invasion is negatively associated with tumor-infiltrating immune cells, which agreed with our results showing that low peripheral LC was significantly associated with vascular invasion.”
ResultPark, J. H., van Wyk, H., Roxburgh, C. S. D., Horgan, P. G., Edwards, J., & McMillan, D. C. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.108 · Cited by 68
“Although the presence of adverse local and systemic characteristics has been previously reported to be associated with increasing T stage, it is of interest that they retain independent prognostic value (Pages et al, 2005; Park et al, 2015b, 2016b; van Wyk et al, 2016).”
BackgroundAhmed, A. S., Schmidt, C., & Brunner, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01438 · Cited by 75
“Likewise, the presence of high levels of infiltrating memory T cells, as measured by immunohistochemistry, correlated with increased survival (186).”
BackgroundHuyghe, N. D., Benidovskaya, E., Stevens, P., & den Eynde, M. V. (2022) · Cancers · doi:10.3390/cancers14092241 · Cited by 69
Phan-Lai, V., Florczyk, S. J., Kievit, F. M., Wang, K., Gad, E., Disis, M. L., & Zhang, M. (2013) · Biomacromolecules · doi:10.1021/bm301928u · Cited by 63
Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling
Barrier, A. J., Roser, F., Boëlle, P., Franc, B., Tsé, C., Brault, D., LACAINE, F., Houry, S., Callard, P., Penna, C., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1210060 · Cited by 63
“They also suggest that the tumor microenvironment and the host’s immune response are of major importance in tumor progression as recently shown (Pages et al., 2005).”
Immune cell profiling to guide therapeutic decisions in rheumatic diseases
Ermann, J., Rao, D. A., Teslovich, N. C., Brenner, M. B., & Raychaudhuri, S. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.71 · Cited by 73
Review. Colon cancer vaccines: an update.
Merika, E., Saif, M. W., Katz, A., Syrigos, K. N., Syrigos, C.-C., & Morse, M. A. (2010) · PubMed · Cited by 79
Expression of antigen processing and presenting molecules in brain metastasis of breast cancer
Liu, Y., Komohara, Y., Domenick, N., Ohno, M., Ikeura, M., Hamilton, R. L., Horbinski, C., Wang, X., Ferrone, S., & Okada, H. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1137-9 · Cited by 62
“In addition to DCs, there is a variety of immune response mediators that can significantly impact the immune surveillance against cancer metastasis, such as chemokines, cytokines and T cell effector molecules [44–46].”
BackgroundCancer immunoediting and “spontaneous” tumor regression
Sengupta, N., MacFie, T. S., MacDonald, T. T., Pennington, D. J., & Silver, A. R. (2009) · Pathology - Research and Practice · doi:10.1016/j.prp.2009.10.001 · Cited by 72
Wu, X., Peng, M., Huang, B., Zhang, H., Wang, H., Huang, B., Xue, Z., Zhang, L., Da, Y., Yang, D., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.038 · Cited by 97
Cytokine gene‐mediated immunotherapy: Current status and future perspectives
Jinushi, M., & Tahara, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01202.x · Cited by 66
Metadata
- Authors
- Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., Meatchi, T., Bruneval, P., Cugnenc, P.-H., Trajanoski, Z., Fridman, W.-H., & Galon, J.
- Affiliations
- Inserm (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Graz University of Technology (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-12-22
- Volume
- 353
- Issue
- 25
- Pages
- 2654-2666
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2096151993
- Semantic Scholar
- 608c79dfb95b1632f3cda7f427350880ee435e8a
- Cited by
- 2,135
- References
- 32
- Citations by year
- 2026: 27 · 2025: 57 · 2024: 66 · 2023: 118 · 2022: 117 · 2021: 141 · 2020: 130 · 2019: 123 · 2018: 123 · 2017: 136 · 2016: 135 · 2015: 145 · 2014: 115 · 2013: 135 · 2012: 108
- FWCI
- 27.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- colorectal cancer, effector memory T cells, tumor-infiltrating lymphocytes, CD8+ T cells, CD45RO+ memory T cells, T-cell markers, lymphatic invasion, perineural invasion, interferon-gamma, granzyme B, granulysin, IRF1, disease-free survival, overall survival, antitumor immunity
- MeSH terms
- Analysis of Variance, Embolism, Flow Cytometry, Humans, Lymphatic Metastasis, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Staging, RNA, Messenger, T-Lymphocytes, Colorectal Neoplasms, Gene Expression, Proportional Hazards Models, Survival Analysis, Polymerase Chain Reaction, Lymphocytes, Tumor-Infiltrating, Leukocyte Common Antigens, CD8-Positive T-Lymphocytes, Microarray Analysis, Protein Tyrosine Phosphatase, Non-Receptor Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.